This panel will examine:

• Best practices in establishing and maintaining pharmaceutical, medical device, health care, and other operations in China
• Clearing regulatory hurdles and navigating China’s legal and business environment
• Standards for the identity, strength, quality, and purity of medicines, food ingredients, and dietary supplements
• Fraud, reimbursement, and off-label enforcement trends
• Linkages between reimbursement, import-export, and quality control measures
• Trade-related aspects of food and drug regulation in China including unique sanitary and phytosanitary measures and technical export and import requirements